Author: Lu Kewen Source: official account: Lu Kewen Studio has been authorized to reprint
These two days, a man named Zhang Shanshan became popular all over the Internet.
The reason is that someone found that Zhang Shanshan has 35 nucleic acid detection companies, covering the whole country, and the companies have been registered in recent months, which caused everyone to be highly alert and thought that the water for nucleic acid detection must be very muddy.
Out of curiosity, I checked Zhang Shanshan’s history through open channels.
Now I will use a very simple statement to tell you the results I have consulted, as well as my analysis and judgment.
First of all, Zhang Shanshan is not a shareholder in these companies, but a “supervisor”. I used to work in this position. Before, when I worked in a company, my boss wanted to register a new company, so he asked me to be a supervisor. He always told me that if you had no shares in this company, it was just a name. Don’t think about it.
To put it this way, supervisors are a post that must be set up when registering a company. They are nominally responsible for supervising whether everyone is breaking the law and requesting the company to report its business. In fact, they are a patchwork to deal with the registration process.
In other words, Zhang Shanshan is not important at all, but who are the shareholders of these companies?
The largest shareholder is Shenzhen Nuclear Gene Technology Co., Ltd. The actual controller of this company is Zhang Heze.
Two shareholders, Ba Ying and Zhang Hezi, went to the same school and became husband and wife after graduation.
Zhang Hezi was admitted to China Medical University in 1990. After graduation, he worked in the DNA Identification Center of Shenzhen Public Security Bureau. In 2000, he set up a Hongshi Decoration Company to do decoration business and also act as a housing intermediary. His wife, Ba Ying, was also a shareholder of the company. The two left the company in 2018.
In 2012, the couple set up Shenzhen Nuclear Gene. The company is mainly engaged in the market of judicial expertise, with Zhang Hezi accounting for 64.7% of the shares and Ba Ying accounting for 12.1% of the shares.
Nuclear gene has developed rapidly. At the end of 2017, when Zhang Hezi was interviewed by Beyond, he said that there are 44 subsidiaries and 29 laboratories in China, and the company’s headquarters is located in Shenzhen Nanshan Smart Park.
The reason for such rapid development is that in 2016, nucleon gene introduced the franchise model. Zhang nucleon said that he planned to open 10000 gene cabins.
In the program “Transcendence”, Zhang Hezi said that his father studied science and engineering, so the three brothers were called nucleon, electron and atom.
In the public information, his brother Zhang Atomic is a shareholder of Guangdong Small Spiral Biomedical Technology Co., Ltd. and Beijing Small Spiral Gene Technology Co., Ltd., and also engaged in the gene industry.
It is estimated that his program was originally used to attract investment, and the interview program has been broadcast circularly in the headquarters of the company, but now it is estimated that he is regretful.
In 2020, with the epidemic situation in China, nuclear gene companies are developing rapidly again.
On January 17, 2021, the Health Commission of Xingtai City, Hebei Province, reported that the nucleic acid test results of Longyao County were falsely reported:
Longyao County was too busy with the second round of nucleic acid testing, so it entrusted Jinan Huaxi Medical Testing Company to undertake nucleic acid testing. Zhai, the person in charge of the company’s collection point, lied to the county health committee on January 14 that all the samples submitted for testing were negative, and reported that positive samples were found on January 16, when the samples were not tested completely and the number and results of tests completed were unknown.
On the 18th, Longyao County started nucleic acid testing for all staff, and took criminal coercive measures against Jinan Huaxi Zhai.
In April 2020, Jinan Huaxi was punished for not putting infectious medical waste in special packaging, which is the second accident.
The legal representative of this Jinan Huaxi Medical Inspection Company is Zhang Hezi’s wife, Ba Ying, and the second shareholder of Nuclear Gene.
Jinan Huaxi is 100% owned by Shandong Nuclear Gene, and Shandong Nuclear Gene is a wholly-owned subsidiary of Shenzhen Nuclear Gene.
Southern Weekend once reported on this company in January 2021. According to the reporter’s calculation at that time, in the half year of 2020 alone, nucleic acid detection business will reach 450 million yuan in turnover and more than 100 cooperative agents will earn more than one million profits because of the nuclear gene winning the bid for detection by local health committees.
A nuclear gene investment manager told the reporter that he “just went to Langfang, Hebei a few days ago, and an agent there received the government’s order, a total of 300000 people, and made millions in two or three days.”
This time, the nuclear gene triggered such a big social discussion that it was their offline accident again. On November 24, when Qilihe District, Lanzhou, was transporting positive infected people, it was found that the health code of some people to be transferred showed negative nucleic acid. After the District Joint Prevention Office reported to the superior, it was found that the source was Lanzhou Nuclear China Sun Laboratory. At 18:00 on the 23rd, the information of the abnormal detection personnel was pushed to Qilihe District Joint Prevention Office.
Lanzhou Nuclear Huaxi explained that it was caused by an error in uploading the information to the working system when entering it.
Internet users later found that Lanzhou Nuclear Huaxi Company was actually established on August 8, 2022, which is only three months, with a registered capital of 10 million yuan and a paid in capital of 0 yuan. It is a shell company.
Then we found out that Zhang Shanshan’s name appeared in 35 nucleic acid companies, and found 62 medical inspection companies with the names of “Nuzi” and “Huaxi” associated with Zhang Shanshan. Then we found the head office of Zhang Hezi and Ba Ying along this line.
Interestingly, I also found such a publicity map of Ba Ying, which said, “The whole group has undertaken the testing of 400 million people, ranking third in the world.”
Well, this is the whole process and background of the event, but these are not the key points. Just know the outline of the event.
Now, according to the old custom, we should wear detective caps, hold a pipe in our mouth, and hold the magic weapon of economic chain analysis in our hands to analyze things.
This is the value that exists when we write about current affairs.
As for the “nucleic acid fraud” attacking nuclear genes on the Internet, nuclear genes are not the only one.
The clinical examination of Zhengzhou Jinyu in Xuchang, Henan, was suspected of causing the spread of the epidemic, and the person in charge of the company was put on criminal record.
Saisi Gene Technology in Hohhot, Inner Mongolia, once had an error in the input of employee information, resulting in positive nucleic acid results, and the company legal person was taken criminal coercive measures.
Nuowell Medical in Hefei, Anhui, was warned of issuing false positive reports and reports beyond the promised time.
This year, at least 10 nucleic acid testing institutions in 7 places were investigated or punished by notification, and Shanghai Zhongke Runda, Beijing Pushi Medicine, Beijing Jinzhun Medicine, Shijiazhuang Hehe Medicine, Kunming Huanji Medicine, etc. were involved in one after another.
Behind the counterfeiting of nucleic acid is a huge nucleic acid detection market, with the scale reaching 1.45 trillion per year.
Recently, ten listed companies of nucleic acid testing released the semi annual report of 2022, with the total revenue of 48.5 billion yuan and the total net profit of 16.3 billion yuan.
The company with the smallest increase in net profit reached 55%, and the company with the largest increase reached 376%.
The huge market capacity makes testing companies try every means to benefit from it. In addition to the incremental method of “positive fraud”, there are also companies that will reduce costs.
For example, Beijing Jinzhun Medical Science Co., Ltd. is the second illegal and criminal case detected since May. The number of test samples sent to this company every day is up to one million, most of them are 10 people, and its profit is 5%.
However, in order to gain more profits, from April 25, Jinzhun Company changed the tube for 10 people to 30 people. It only absorbed one third of the liquid in a test tube and mixed it together for testing. The profits increased sharply, and finally it overturned.
The deputy director of the Fangshan District Health Commission and the head of the medical administration department had an accident for similar reasons.
Yu Luming, the former director of the Beijing Health Commission, was investigated, one of which was “suspected of nucleic acid test commission”.
Nucleic acid testing has formed a huge chain of interests, in which a large number of companies and individuals make profits, not to mention reluctant to leave this economic chain.
It also triggered a strange phenomenon that nucleic acid detection companies piled up for IPO.
By the way, this is the focus of this news interpretation.
A large number of people of all kinds are preparing to make a fortune by relying on the economic chain generated by this wave of epidemic, resulting in many strange phenomena.
In 2022, there will be 5 nucleic acid testing enterprises, namely Kangwei Century, Dakewei, Zhishan Biology, Ribao and Phelps Biology.
Dake here is a company that operates nucleic acid detection tubes. From 2019 to 2021, its main revenues will be 430 million yuan, 600 million yuan and 800 million yuan respectively. The net profits in 2020 and 2021 will increase by 488% and 27% respectively.
The company’s largest shareholder is Wu Yingjie, born in 1995, and its fifth largest shareholder is He Zhenglong, born in 2005 at the age of 17.
However, the sustainability of profits of all companies that rely on the epidemic industry chain has been questioned by the market.
Especially recently, when China’s epidemic prevention policy is likely to change, it is urgent for these companies to make money quickly through IPO.
Because once the epidemic changes, these companies will never have the opportunity to go public.
The protagonist of this article, who has nuclear genes from 46 subsidiaries and 31 laboratories, started IPO in the first half of 2022 and is ready to go public.
Therefore, it is not difficult to understand why the nuclear gene suddenly registered dozens of companies in such a short time, and also publicized in public that it “undertakes the detection of 400 million people”.
The purpose of making big and high-profile publicity is to go public.
If we miss the time point of the epidemic, this opportunity will not come again, and the turnover and profits will plummet. Therefore, companies that rely on the epidemic industry chain across the country are eager to go public.
The Shanghai and Shenzhen Stock Exchanges have also found out recently that they will strictly review the IPO applications of nucleic acid testing enterprises, paying special attention to the sustainable operation ability of enterprises.
Yisheng Biology, which is responsible for COVID-19’s testing materials, was the first to open the door and cancelled the review of its listing application.
Because listing requires a great cost, if every listed company fails to list, it will be a great loss to the company’s finance.
In order to get listed before the end of the epidemic, the nuclear gene that has been busy for listing for at least one year will register so many companies and spread its business to cities across the country in such a short time, regardless of public influence.
In fact, according to the minds of the old foxes in the shopping mall, they usually do things low-key and low-key again. However, nuclear gene is so desperate this time, which shows that it is really in a hurry and there is no time to play cards slowly.
So the logic behind this wave of news events is clear:
1. The companies may predict that the epidemic situation will change greatly and accelerate the IPO urgently.
2. In order to make a big deal, Nuclear Gene hastily registered its company and expanded its business, intending to rush to the market before the door was closed.
3. However, the wave of nuclear genes was not well managed as expected. The car overturned in Lanzhou, triggering the Zhang Shanshan incident, which was finally exposed to the public.
There is nothing to say, just ask the gatekeepers of the Shanghai and Shenzhen Stock Exchanges to take good control of the sustainable profitability of enterprises, especially companies that rely too much on the epidemic industrial chain, so as not to cause unnecessary losses to shareholders.
Finally, the economic chain analysis method is really easy to use, and we solved the case again.